Scientists have developed a user-friendly approach to creating 'theranostics' — therapy combined with diagnostics — that target specific tumors and diseases. They have developed a novel method to prepare cell-penetrating nanoparticles called 'metallocorrole/protein nanoparticles.' The theranostics could both survive longer in the body and better snipe disease targets.